KBC Group NV increased its stake in Deere & Company by 1% in Q1, signaling steady institutional interest in the industrial ...

Spire Wealth Management increased its Airbnb holdings by 40.1% in Q1, buying an additional 260 shares. This brings their ...

Vertex Pharmaceuticals secured EU approval for ALYFTREK, a next-gen cystic fibrosis therapy boasting a better efficacy ...

Bessemer Group significantly trimmed its investment in Regeneron Pharmaceuticals during the first quarter, slashing its stake ...

Bristol-Myers Squibb is running a rigorous Phase 2/3 clinical trial on ozanimod, aiming to help children with moderate to severe ulcerative colitis who haven’t responded to conventional treatments.

Cigna has announced that starting September 15, 2025, it will begin covering RhinAer, a minimally invasive treatment for chronic rhinitis. This update means RhinAer is no longer classified as ...

Capital Advisors Wealth Management LLC nearly doubled its Starbucks stake in Q1, upping its share count by 90.1% to 6,812.

Boston Scientific has surged 40.5% in the past year, outpacing both its industry and the S&P 500. The WATCHMAN FLX and ...

Bessemer Group Inc. significantly reduced its position in CVS Health, cutting holdings by 59.2% in Q1 2025. The fund sold ...

Mirae Asset Global Investments recently increased its stake in Mondelez International by 14.9%, totaling $28.38 million in ...

KLA Corporation’s trading volume sank 56% to $461 million on June 30, 2025, yet its stock price edged up 0.66%. KLA remains a ...

Libra Wealth LLC invested approximately $341,000 in Analog Devices during Q1, acquiring 1,693 shares of the semiconductor ...